Qiaoling Pan
79 Qingchun Rd
Hangzhou, 310003, China
Hangzhou, 310003, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications
MELD 3.0 Improves Risk Stratification and Mortality Prediction in Hepatorenal Syndrome-Acute Kidney Injury: A Multicentre Study.
Journal: Alimentary pharmacology & therapeutics
Published: March 03, 2025
Mesenchymal stem cell-derived extracellular vesicles attenuate periductal fibrosis by inhibiting Th17 differentiation in human liver multilineage organoids and Mdr2-/- mice.
Journal: Journal of nanobiotechnology
Published: January 10, 2025
Editorial: Assessing the Prognosis of Patients With HBV and ACLF-Comorbidities Matter. Authors' Reply.
Journal: Alimentary pharmacology & therapeutics
Published: October 30, 2024
Human placenta mesenchymal stromal cells alleviate intestinal inflammation and repair intestinal barrier function by activating AMPK-FXR pathway.
Journal: Communications biology
Published: August 07, 2024
aCCI-HBV-ACLF: A Novel Predictive Model for Hepatitis B Virus-Related Acute-On-Chronic Liver Failure.
Journal: Alimentary pharmacology & therapeutics
Published: June 11, 2024
PLGA micro/nanoparticle vaccination elicits non-tumor antigen specific resident memory CD8+ T cell protection from hepatocellular carcinoma.
Journal: Nanoscale
Published: June 04, 2024
Serum metabonomics reveal the effectiveness of human placental mesenchymal stem cell therapy for primary sclerosing cholangitis.
Journal: Stem cell research & therapy
Published: April 29, 2024
ROS-responsive nanoparticle delivery of obeticholic acid mitigate primary sclerosing cholangitis.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: April 12, 2024
MSCs alleviate LPS-induced acute lung injury by inhibiting the proinflammatory function of macrophages in mouse lung organoid-macrophage model.
Journal: Cellular and molecular life sciences : CMLS
Published: September 26, 2023
Mesenchymal stem cells alleviate mouse liver fibrosis by inhibiting pathogenic function of intrahepatic B cells.
Journal: Hepatology (Baltimore, Md.)
Published: September 25, 2023
Last Updated: 09/26/2026